{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:29:59Z","timestamp":1773786599840,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01863-0","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:01:45Z","timestamp":1761368505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LINC00885 promotes lung squamous cell carcinoma by upregulating SLBP expression to activate PI3K\/Akt pathway"],"prefix":"10.1007","volume":"25","author":[{"given":"Lele","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"2","key":"1863_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/CCO.0000000000000429","volume":"30","author":"F Oberndorfer","year":"2018","unstructured":"Oberndorfer F, M\u00fcllauer L. Molecular pathology of lung cancer: current status and perspectives. Curr Opin Oncol. 2018;30(2):69\u201376.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"1863_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21037\/cco.2019.02.02","volume":"8","author":"J Chen","year":"2019","unstructured":"Chen J, Soudy H. Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report. Chin Clin Oncol. 2019;8(3):29.","journal-title":"Chin Clin Oncol"},{"key":"1863_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-319-40389-2_2","volume":"170","author":"J Rodriguez-Canales","year":"2016","unstructured":"Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and molecular classification of lung cancer. Cancer Treat Res. 2016;170:25\u201346.","journal-title":"Cancer Treat Res"},{"issue":"6","key":"1863_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.21037\/tlcr.2019.10.13","volume":"8","author":"H Tu","year":"2019","unstructured":"Tu H, et al. Screening of potential biomarkers and their predictive value in early stage non-small cell lung cancer: a bioinformatics analysis. Transl Lung Cancer Res. 2019;8(6):797\u2013807.","journal-title":"Transl Lung Cancer Res"},{"key":"1863_CR5","doi-asserted-by":"crossref","unstructured":"Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519\u201325.","DOI":"10.1038\/nature11404"},{"issue":"4","key":"1863_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cllc.2018.03.014","volume":"19","author":"FR Hirsch","year":"2018","unstructured":"Hirsch FR, et al. Molecular and immune biomarker testing in squamous-cell lung cancer: effect of current and future therapies and technologies. Clin Lung Cancer. 2018;19(4):331\u20139.","journal-title":"Clin Lung Cancer"},{"key":"1863_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2019.12.005","volume":"140","author":"JM Sands","year":"2020","unstructured":"Sands JM, et al. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas. Lung Cancer. 2020;140:35\u201341.","journal-title":"Lung Cancer"},{"issue":"3","key":"1863_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393\u2013407.","journal-title":"Cell"},{"issue":"7","key":"1863_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.116.305510","volume":"116","author":"B Yan","year":"2015","unstructured":"Yan B, et al. LncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116(7):1143\u201356.","journal-title":"Circ Res"},{"issue":"1","key":"1863_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0449-4","volume":"10","author":"W Ni","year":"2017","unstructured":"Ni W, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2017;10(1):91.","journal-title":"J Hematol Oncol"},{"issue":"25","key":"1863_CR11","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/onc.2016.521","volume":"36","author":"H Xiong","year":"2017","unstructured":"Xiong H, et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene. 2017;36(25):3528\u201340.","journal-title":"Oncogene"},{"key":"1863_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.602035","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu X, et al. Identification of potential long non-coding RNA expression quantitative trait methylations in lung adenocarcinoma and lung squamous carcinoma. Front Genet. 2020;11:602035.","journal-title":"Front Genet"},{"key":"1863_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153566","volume":"226","author":"H Li","year":"2021","unstructured":"Li H, Zhao Q, Tang Z. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p\/miR-6870-5p to upregulate PHF12\/FOXP4. Pathol Res Pract. 2021;226:153566.","journal-title":"Pathol Res Pract"},{"issue":"8\u20139","key":"1863_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41417-021-00410-9","volume":"29","author":"H Zhu","year":"2022","unstructured":"Zhu H, et al. LncRNA LINC00649 recruits TAF15 and enhances MAPK6 expression to promote the development of lung squamous cell carcinoma via activating MAPK signaling pathway. Cancer Gene Ther. 2022;29(8\u20139):1285\u201395.","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"1863_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.21037\/tlcr-19-701","volume":"9","author":"Y Wu","year":"2020","unstructured":"Wu Y, et al. LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1. Transl Lung Cancer Res. 2020;9(4):1138\u201348.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"1863_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13062-021-00314-6","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. LINC00885 promotes cervical cancer progression through sponging miR-3150b-3p and upregulating BAZ2A. Biol Direct. 2022;17(1):4.","journal-title":"Biol Direct"},{"issue":"3","key":"1863_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.14715\/cmb\/2023.69.3.24","volume":"69","author":"Z Xia","year":"2023","unstructured":"Xia Z, Wang Q, Lu P. LncRNA LINC00885 promotes bladder cancer progression by targeting the miR-98-5p\/PBX3 axis. Cell Mol Biol (Noisy-le-grand). 2023;69(3):163\u20138.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"1863_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/CBM-230143","volume":"39","author":"P He","year":"2024","unstructured":"He P, et al. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p. Cancer Biomark. 2024;39(1):63\u201378.","journal-title":"Cancer Biomark"},{"issue":"W1","key":"1863_CR19","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102.","journal-title":"Nucleic Acids Res"},{"key":"1863_CR20","doi-asserted-by":"publisher","first-page":"D202","DOI":"10.1093\/nar\/gkq1056","volume":"39","author":"JH Yang","year":"2011","unstructured":"Yang JH, et al. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2011;39:D202\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1863_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1863_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3892\/ol.2023.14141","volume":"27","author":"M Alhawamdeh","year":"2024","unstructured":"Alhawamdeh M, et al. Effect of IFN-\u03b3 encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer. Oncol Lett. 2024;27(1):8.","journal-title":"Oncol Lett"},{"issue":"1","key":"1863_CR23","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/21691401.2019.1601099","volume":"47","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang H, Li Y. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP. Artif Cells Nanomed Biotechnol. 2019;47(1):1458\u201365.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"1863_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan AC. Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer. 2020;11(3):511\u20138.","journal-title":"Thorac Cancer"},{"issue":"41","key":"1863_CR25","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY. Lncrna-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661\u20137.","journal-title":"Oncogene"},{"issue":"15","key":"1863_CR26","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2174\/1568026617666161116144744","volume":"17","author":"MM Kumar","year":"2017","unstructured":"Kumar MM, Goyal R. LncRNA as a therapeutic target for angiogenesis. Curr Top Med Chem. 2017;17(15):1750\u20137.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"1863_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/15384047.2020.1842717","volume":"22","author":"X Zhou","year":"2021","unstructured":"Zhou X, et al. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC. Cancer Biol Ther. 2021;22(3):196\u2013203.","journal-title":"Cancer Biol Ther"},{"key":"1863_CR28","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12097","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. FOXP3-induced LINC00885 promotes the proliferation and invasion of cervical cancer cells. Mol Med Rep. 2021;23(6):458.","journal-title":"Mol Med Rep"},{"key":"1863_CR29","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2147\/CMAR.S291778","volume":"13","author":"H Chen","year":"2021","unstructured":"Chen H, et al. Long intergenic non-coding RNA LINC00885 promotes tumorigenesis of cervical cancer by upregulating MACC1 expression through serving as a competitive endogenous RNA for microRNA-432-5p. Cancer Manag Res. 2021;13:1435\u201347.","journal-title":"Cancer Manag Res"},{"key":"1863_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197407","author":"MC Abba","year":"2020","unstructured":"Abba MC, et al. LINC00885 a novel oncogenic long non-coding RNA associated with early stage breast cancer progression. Int J Mol Sci. 2020;21(19):7407.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1863_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"AM Florea","year":"2011","unstructured":"Florea AM, B\u00fcsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011;3(1):1351\u20132171.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1863_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212\u201326.","journal-title":"Trends Cell Biol"},{"issue":"10","key":"1863_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/2159-8290.CD-13-0202","volume":"3","author":"FA Karreth","year":"2013","unstructured":"Karreth FA, Pandolfi PP. CeRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3(10):1113\u201321.","journal-title":"Cancer Discov"},{"issue":"2","key":"1863_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/15384101.2020.1867782","volume":"20","author":"G Hou","year":"2021","unstructured":"Hou G, et al. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p\/ MAPK6 axis. Cell Cycle. 2021;20(2):179\u201393.","journal-title":"Cell Cycle"},{"key":"1863_CR35","doi-asserted-by":"publisher","first-page":"11195","DOI":"10.2147\/OTT.S198367","volume":"12","author":"Y Bai","year":"2019","unstructured":"Bai Y, et al. Long non-coding RNA HOXA11-AS promotes non-small cell lung cancer tumorigenesis through microRNA-148a-3p\/DNMT1 regulatory axis. Onco Targets Ther. 2019;12:11195\u2013206.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1863_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/CBM-191084","volume":"28","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Mir-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Cancer Biomark. 2020;28(1):73\u20139.","journal-title":"Cancer Biomark"},{"issue":"44","key":"1863_CR37","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1038\/onc.2013.451","volume":"33","author":"A Formosa","year":"2014","unstructured":"Formosa A, et al. Micrornas, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014;33(44):5173\u201382.","journal-title":"Oncogene"},{"issue":"1","key":"1863_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1487-2","volume":"39","author":"G Deng","year":"2020","unstructured":"Deng G, et al. Circular RNA circRHOBTB3 acts as a sponge for miR-654-3p inhibiting gastric cancer growth. J Exp Clin Cancer Res. 2020;39(1):1.","journal-title":"J Exp Clin Cancer Res"},{"key":"1863_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.092","volume":"700","author":"X Wu","year":"2019","unstructured":"Wu X, et al. Molecular characterization and expression patterns of stem-loop binding protein (SLBP) genes in protogynous hermaphroditic grouper, Epinephelus coioides. Gene. 2019;700:120\u201330.","journal-title":"Gene"},{"issue":"1","key":"1863_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12011-015-0296-5","volume":"166","author":"J Brocato","year":"2015","unstructured":"Brocato J, et al. A potential new mechanism of arsenic carcinogenesis: depletion of stem-loop binding protein and increase in polyadenylated canonical histone H3.1 mRNA. Biol Trace Elem Res. 2015;166(1):72\u201381.","journal-title":"Biol Trace Elem Res"},{"key":"1863_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-020-00865-y","author":"Y Shinden","year":"2020","unstructured":"Shinden Y, et al. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes. J Hum Genet. 2021;66(5):519-534.","journal-title":"J Hum Genet"},{"issue":"8","key":"1863_CR42","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ctrv.2014.06.006","volume":"40","author":"JT Beck","year":"2014","unstructured":"Beck JT, Ismail A, Tolomeo C. Targeting the phosphatidylinositol 3-kinase (PI3K)\/AKT\/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma. Cancer Treat Rev. 2014;40(8):980\u20139.","journal-title":"Cancer Treat Rev"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01863-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:52:39Z","timestamp":1764917559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01863-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01863-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"329"}}